http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : 노재경(Jae Kyung Rho) (검색결과 2 건)
- 무료
- 기관 내 무료
- 유료
-
-
표홍렬(Hong Ryull Pyo),서창옥(Chang Ok Suh),김귀언(Gwi Eon Kim),노재경(Jae Kyung Rho) 대한방사선종양학회 1995 Radiation Oncology Journal Vol.13 No.2
Purpose : Traditionally the patients with early stage non-hodgkin's lymphoma of the head and neck was treated with radiotherapy. But the results were not satisfactory due to distant relapse. Although combined treatment with radiotherapy and chemotherapy was tried with some improved results and chemotherapy alone was also tried in recent years, the choice of treatment for the patients with early stage non-Hodgkin's lymphoma of the head and neck has not been defined. Therefore, in order to determine the optimum treatment method, we analysed retrospectively the outcomes of the patients with Ann Arbor stage Ⅰ and Ⅱ non-Hodgkin's lymphoma localized to the head and neck who were treated at Severance Hospital. Materials and Methods : 159 patients with stage Ⅰ and Ⅱ non-Hodgkin's lymphoma localized to the head and neck were treated at out hospital from January. 1979 to December. 1992. Of these patients, 114 patients whose primary sites were Waldeyer's ring or nodal region and received prescribed radiation dose and/or more than 2 cycles of chemotherapy were selected to analyze the outcomes according to the treatment methods (radiotherapy alone, chemotherapy alone, and combined treatment with radiotherapy and chemotherapy). Results : Five year overall actuarial survival of the patients whose primary site was Waldeyer's ring was 62.5% and that of the patients whose primary site was nodal region was 53.8%. There was no statistically significant difference between survivals of both groups. Initial response rate to radiotherapy, chemotherapy, and combined treatment was 92%, 83%, 94% respectively, and 5 year relapse free survival was 49.9%, 52.4%, 58.5% respectively (statistically not significant). In the patients with stage Ⅰ, 3 year relapse free survival of chemotherapy alone group was 75% and superior to other treatment groups. In the patients with stage Ⅱ, combined treatment group revealed the best result with 60.1% of 3 year relapse free survival. The effect of sequential schedule of each treatment method in the patients who were treated by combined modality was analyzed and the sequence of primary chmotherapy+radiotherapy+maintenance chemotherapy showed the best result (3 year relapse free survival was 79.1%). There was no significant survival difference between BACOP regimen and CHOP regimen. REsponse to treatment was only one significant (p<0.005) prognostic factor on univariate analysis and age and mass size was marginally significant (p<0.1). On multivariate analysis age (p=0.026) and mass size (p=0.013) were significant prognostic factor for the relapse free survival. Conclusion : In summary, the patients, who have non-Hodgkin's lymphoma fo the head and neck with stage Ⅰ and mass size smaller than 10cm, can be treated by chemotherapy alone, but remainder should be treated by combined treatment method and the best combination schedule was the sequence of initial chemotherapy followed by radiotherapy and maintenance chemotherapy.
ScienceON연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
